<DOC>
	<DOC>NCT00196313</DOC>
	<brief_summary>This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 13 weeks of treatment with the option to extend blinded therapy for an additional 13 weeks. The overall study duration will be 6-9 months. Patients will be required to record menstrual pain in a daily diary.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain</brief_title>
	<detailed_description />
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Sexually na√Øve and agree to abstain from sex during the study Moderate to severe menstrualrelated pelvic pain Regular spontaneous menstrual cycles Any contraindication to the use of oral contraceptives Treatment with an oral contraceptive within the previous 3 months Previous treatment failure with an extended oral contraceptive regimen</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cyclic pelvic pain</keyword>
	<keyword>dysmenorrhea</keyword>
	<keyword>oral contraceptives</keyword>
</DOC>